68Ga-PSMA, N,N'-Bis(2-hydroxybenzyl)Ethylenediamine-N,N'-Diacetic Acid (HBED)-PET/CT in the Evaluation of the Biochemical Relapse in Patients With a History of Prostate Cancer Radically Treated
Phase of Trial: Phase II
Latest Information Update: 10 Jan 2018
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 05 Jan 2018 Planned End Date changed from 1 Nov 2017 to 1 Nov 2018.
- 05 Jan 2018 Planned primary completion date changed from 1 Nov 2017 to 1 Nov 2018.
- 10 Jun 2017 Biomarkers information updated